These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38073352)

  • 1. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
    Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
    Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of single-photon emission computed tomography aided botulinum toxin injection in cervical dystonia: A double-blind, randomized study.
    Teng F; Malam Djibo I; Chen S; Su J; Pan Y; Zhang X; Xu Y; Feng L; Pan L; Jin L
    Parkinsonism Relat Disord; 2021 Oct; 91():77-82. PubMed ID: 34537494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study).
    Tyślerowicz M; Dulski J; Gawryluk J; Sławek J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
    Marciniec M; Szczepańska-Szerej A; Rejdak K
    Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.
    Hefter H; Samadzazeh S; Rosenthal D
    J Neurol; 2021 Jan; 268(1):206-213. PubMed ID: 32761340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol Sci; 2020 Sep; 416():117015. PubMed ID: 32682125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD).
    Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J
    Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B for cervical dystonia.
    Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
    Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.